New study tests which tailbone pain treatment works best
NCT ID NCT07497269
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of radiofrequency treatment—pulsed and conventional—for people with long-lasting tailbone pain that hasn't improved with other treatments. Ninety adults aged 18 to 80 will be randomly assigned to one of the two procedures. The goal is to see which method better reduces pain, improves daily function, and enhances sleep quality.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiofrequency ablation (pulsed or conventional)
- What this could lead to
- If it works, this could point toward a better, less painful treatment option for people with stubborn tailbone pain.
- What could go wrong
- This is a small, early-stage trial with only 90 participants. It may not show a clear winner, and results might not apply to everyone with tailbone pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACK PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Adana City Training and Research Hospital
Adana, Adana, Turkey (Türkiye)
-
Tobb Etü Hospital
Ankara, Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rewiring the brain to fight back pain?
- Breathing exercises may enhance physiotherapy for spine condition
- Can tape or therapy soothe Post-COVID back pain?
- Laser and electromagnetic combo targets back pain without drugs
- Hands-On therapy may soothe cystic fibrosis pain without drugs
- Deep breaths for back pain: simple breathing technique tested as pain reliever